Absence of pharmacokinetic interaction between ofloxacin and fenbufen in rats.
The possible pharmacokinetic interaction between a new quinolone and fenbufen was investigated by comparing the plasma concentration-time profiles and serum protein binding of ofloxacin, fenbufen and its active metabolite, felbinac, in rats. The rats were administered intravenous doses of ofloxacin (5 mg kg-1), fenbufen (10 mg kg-1) alone or concomitantly. The plasma elimination half-lives were about 55 min in both groups. A slight elevation of plasma concentration of ofloxacin and a small decrease of its total body clearance were observed after its coadministration with fenbufen. The extent of ofloxacin binding to rat serum tended to be slightly reduced by fenbufen which coexisted at relatively high concentrations. Plasma concentration-time curves, pharmacokinetic parameters and serum protein binding of fenbufen and felbinac were not affected by the coadministration with ofloxacin. These results suggest that any substantive pharmacokinetic interaction may be unlikely after the concomitant administration of ofloxacin and fenbufen.
Katagiri
Y
Y
Department of Pharmacy, Shimane Medical University Hospital, Izumo, Japan.
Naora
K
K
Ichikawa
N
N
Hayashibara
M
M
Iwamoto
K
K
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D008297:Male; D015242:Ofloxacin / Q000493:pharmacokinetics / Q000494:pharmacology*; D010648:Phenylacetates / Q000097:blood / Q000493:pharmacokinetics; D010654:Phenylbutyrates / Q000493:pharmacokinetics / Q000494:pharmacology*; D011485:Protein Binding; D051381:Rats; D011919:Rats, Inbred Strains
D001798:Blood Proteins; D010648:Phenylacetates; D010654:Phenylbutyrates; C012776:biphenylylacetic acid; C010725:fenbufen; D015242:Ofloxacin